Healthcare-Life-Sciences Market Reports

Comprehensive industry analysis, market size, and forecast for healthcare-life-sciences.

Showing 411 - 420 of 1045 reports

France Ophthalmic Viscoelastic Devices Market Size, Share & Forecast 2026–2034

Report Highlights Country: France Market: Ophthalmic Viscoelastic Devices Market Market Size 2024: USD 78.5 million Market Size 2032: USD 121.3 million CAGR: 5.6% Base Year: 2025 Forecast Period: 2026-2032 France Ophthalmic Viscoelastic Devices: Market Overview France represents the third-largest ophthalmic viscoelastic devices market in Europe, … Read More
Published June 2026

Japan Ophthalmic Viscoelastic Devices Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 89.2 million Market Size 2032: USD 126.8 million CAGR: 4.5% Market Definition: Gel-like substances used during ophthalmic surgeries to maintain anterior chamber depth, protect corneal endothelium, and facilitate surgical procedures including cataract extraction and intraocular lens implantation Leading Companies: … Read More
Published June 2026

Peptides Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $48.2 billion Market Size 2034: $109.7 billion CAGR: 8.6% Market Definition: Peptides are short chains of amino acids that function as signaling molecules, hormones, and therapeutic agents across pharmaceutical, cosmetic, and food industries. The market encompasses synthetic and natural peptides … Read More
Published June 2026

Life Science Reagent Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 86.7 billion Market Size 2034: USD 154.2 billion CAGR: 5.9% Market Definition: Life science reagents encompass chemical compounds, biological materials, and analytical substances used in research, diagnostics, and pharmaceutical development. These include antibodies, enzymes, buffers, cell culture media, molecular … Read More
Published June 2026

Alzheimer's Drugs Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 4.8 billion Market Size 2034: USD 12.7 billion CAGR: 10.2% Market Definition: Pharmaceutical treatments targeting Alzheimer's disease pathology, including cholinesterase inhibitors, NMDA receptor antagonists, and disease-modifying therapies. Encompasses prescription medications for mild cognitive impairment through severe dementia stages. Leading … Read More
Published June 2026

Immersive Technology in Healthcare Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 8.2 billion Market Size 2034: USD 47.8 billion CAGR: 19.4% Market Definition: Immersive technology in healthcare encompasses virtual reality, augmented reality, mixed reality, and extended reality solutions designed for medical training, patient treatment, surgical planning, rehabilitation, and mental health … Read More
Published June 2026

Applied AI in Healthcare Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $15.1 billion Market Size 2034: $148.4 billion CAGR: 26.1% Market Definition: Applied AI in healthcare encompasses machine learning algorithms, natural language processing, computer vision, and predictive analytics deployed across clinical workflows, drug discovery, medical imaging, patient monitoring, and healthcare administration … Read More
Published June 2026

Novel Cell Sorting and Separation Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $2.8 billion Market Size 2034: $6.4 billion CAGR: 8.6% Market Definition: Novel cell sorting and separation encompasses advanced technologies including microfluidics, magnetic-activated cell sorting, fluorescence-activated cell sorting, and acoustic wave separation for isolating specific cell populations. These systems enable precise … Read More
Published June 2026

Wegener's Granulomatosis Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.8 billion Market Size 2034: USD 3.4 billion CAGR: 6.5% Market Definition: Wegener's granulomatosis treatment encompasses immunosuppressive therapies, biologics, and corticosteroids for managing granulomatosis with polyangiitis, a rare autoimmune vasculitis affecting multiple organ systems. Treatment protocols focus on inducing … Read More
Published June 2026

SJS/TEN Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $324.7 million Market Size 2034: $587.2 million CAGR: 6.1% Market Definition: SJS/TEN treatment encompasses therapeutic interventions for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, severe skin reactions characterized by widespread skin and mucous membrane detachment. Treatment focuses on supportive care, immunosuppression, … Read More
Published June 2026